we can see that the hazard ratio for overall survival was 0.75, while the median survival…

aplan Meier curves. That is a new kind of evaluation for patients with lung cancer that are not receiving immuno-checkpoint inhibitors. So the Kaplan Meier curve in a plateau, in particular in the end part, and this is very, very interesting. So we are waiting, we are expecting to collect the evidence in the next year, potentially to present the median in this particular setting. 내년이면 mOS 몇개월 나온다는 걸까 ᄃᄃ